Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Geet Madhukar"'
Autor:
Geet Madhukar, Naidu Subbarao
Among the major altered pathways in head and neck squamous cell carcinoma, AKT/mTORC1/S6K and NRF2/KEAP1 pathway are quite significant. The overexpression and overstimulation of proteins from both these pathways makes them the promising candidates in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51a89974f6adf989e1498522504b73b
Autor:
Geet Madhukar, Sangeeta Kumari, Pragyan Parimita Rath, Samudrala Gourinath, Neelima Mondal, Naidu Subbarao
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer, globally. Its high mortality rates hasn’t changed much in the last three decades and the overall survival is still less than 5 years. Therefore, there is an urgent need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db2bd36c3ffd63279bafea3ec93c7d9
https://doi.org/10.21203/rs.3.rs-2298439/v1
https://doi.org/10.21203/rs.3.rs-2298439/v1
Autor:
Dipendra Bhandari, Sangita Kachhap, Geet Madhukar, Kiran Kumar Adepu, Andriy Anishkin, Jin-Ran Chen, Sree V. Chintapalli
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 14778
Previous research has indicated that various metabolites belonging to phenolic acids (PAs), produced by gut microflora through the breakdown of polyphenols, help in promoting bone development and protecting bone from degeneration. Results have also s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4a986868cc62938056226fd90b49238
https://pubmed.ncbi.nlm.nih.gov/36499106
https://pubmed.ncbi.nlm.nih.gov/36499106
Autor:
Geet Madhukar, Naidu Subbarao
Publikováno v:
In silico pharmacology. 10(1)
Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the most common form of cancer worldwide. It has high incidence and mortality rate making it one of the top causes of cancer related deaths. Tremendous efforts have being made towards treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a78b34a8da62edde7d0b7388b3c5e222
https://pubmed.ncbi.nlm.nih.gov/35928028
https://pubmed.ncbi.nlm.nih.gov/35928028
Autor:
Naidu Subbarao, Geet Madhukar
Publikováno v:
Current cancer drug targets. 21(5)
Head and neck squamous cell carcinoma (HNSCC) continues to be a global public health burden even after a tremendous development in its treatment. It is a heterogeneous cancer of upper aero-digestive tract. The contemporary strategy to treat cancer is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::698e2acb93686f82e6d675657c5114a8
https://pubmed.ncbi.nlm.nih.gov/33372876
https://pubmed.ncbi.nlm.nih.gov/33372876
Autor:
Geet Madhukar, Naidu Subbarao
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers, globally. Its high mortality rates remained unaltered in the last three decades, therefore, there is an enormous need for novel therapeutics. The most frequent somatical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1a3c1be36082bfe7db4e57597ea647